Zeneca: Difference between revisions

Latest revision as of 04:01, 13 February 2025

Zeneca[edit]

Zeneca was a British multinational pharmaceutical company that was formed in 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries (ICI). Zeneca was headquartered in London, United Kingdom.

History[edit]

The formation of Zeneca was part of a strategic move by ICI to focus on its core chemicals business. Zeneca quickly established itself as a major player in the pharmaceutical industry, with a strong emphasis on research and development.

In 1999, Zeneca merged with the Swedish pharmaceutical company Astra AB to form AstraZeneca, one of the world's leading pharmaceutical companies. This merger was driven by the complementary strengths of the two companies, with Astra's expertise in gastrointestinal and cardiovascular drugs and Zeneca's strong oncology and respiratory portfolios.

Products[edit]

During its existence, Zeneca developed and marketed a range of pharmaceutical products. Some of the notable drugs included:

Nolvadex (tamoxifen): A drug used in the treatment of breast cancer.
Zoladex (goserelin): A medication used to treat prostate cancer and breast cancer.
Seroquel (quetiapine): An antipsychotic used to treat schizophrenia and bipolar disorder.

Research and Development[edit]

Zeneca invested heavily in research and development, focusing on areas such as oncology, cardiovascular, and respiratory diseases. The company established several research facilities around the world, including in the United Kingdom and the United States.

Merger with Astra[edit]

The merger between Zeneca and Astra was announced in December 1998 and completed in April 1999. The new company, AstraZeneca, became one of the largest pharmaceutical companies in the world, with a strong presence in both Europe and the United States.

Legacy[edit]

Although Zeneca as a standalone company ceased to exist after the merger, its legacy continues through AstraZeneca. The merger allowed for the pooling of resources and expertise, leading to the development of new and innovative treatments for various diseases.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Zeneca''' was a British multinational pharmaceutical company, established in 1993 through the demerger of the pharmaceutical operations from [[Imperial Chemical Industries|ICI]]. It was later merged with the Swedish company [[Astra AB]] in 1999 to form [[AstraZeneca]].
+== Zeneca ==
-==History==
+[[File:Zeneca_logo.svg|thumb|right|The Zeneca logo]]
-Zeneca was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of ICI into a separate company. The decision to demerge was taken due to the increasing divergence between the business models of the pharmaceutical and bulk chemicals businesses. The demerger was also part of a broader trend of companies spinning off their pharmaceutical operations to focus on core businesses.
-In 1999, Zeneca and Astra AB announced their intention to merge, with the new company to be called AstraZeneca. The merger was completed in April 1999, creating the third largest pharmaceutical company in the world.
+Zeneca was a British multinational pharmaceutical company that was formed in 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of [[Imperial Chemical Industries]] (ICI). Zeneca was headquartered in [[London]], [[United Kingdom]].
-==Products==
+=== History ===
-Zeneca developed and marketed a wide range of pharmaceutical products. These included [[oncology]] drugs such as [[tamoxifen]], used in the treatment of breast cancer, and [[Zoladex]], used in the treatment of prostate cancer. It also produced [[cardiovascular]] drugs such as [[Atenolol]], used in the treatment of high blood pressure, and [[Seloken]], used in the treatment of angina and heart failure.
-==Research and Development==
+The formation of Zeneca was part of a strategic move by ICI to focus on its core chemicals business. Zeneca quickly established itself as a major player in the pharmaceutical industry, with a strong emphasis on research and development.
-Zeneca was known for its strong commitment to research and development. It invested heavily in the development of new drugs and treatments, with a particular focus on oncology, cardiovascular diseases, and [[gastroenterology]]. Its research efforts led to the development of several breakthrough drugs, including the first selective estrogen receptor modulator, tamoxifen.
-==Legacy==
+In 1999, Zeneca merged with the Swedish pharmaceutical company [[Astra AB]] to form [[AstraZeneca]], one of the world's leading pharmaceutical companies. This merger was driven by the complementary strengths of the two companies, with Astra's expertise in gastrointestinal and cardiovascular drugs and Zeneca's strong oncology and respiratory portfolios.
-The legacy of Zeneca continues in the form of AstraZeneca, which has become one of the world's leading pharmaceutical companies. Many of the drugs developed by Zeneca continue to be marketed by AstraZeneca and are used in the treatment of a wide range of conditions.
+=== Products ===
+During its existence, Zeneca developed and marketed a range of pharmaceutical products. Some of the notable drugs included:
+* '''[[Nolvadex]] (tamoxifen)''': A drug used in the treatment of breast cancer.
+* '''[[Zoladex]] (goserelin)''': A medication used to treat prostate cancer and breast cancer.
+* '''[[Seroquel]] (quetiapine)''': An antipsychotic used to treat schizophrenia and bipolar disorder.
+=== Research and Development ===
+Zeneca invested heavily in research and development, focusing on areas such as oncology, cardiovascular, and respiratory diseases. The company established several research facilities around the world, including in the United Kingdom and the United States.
+=== Merger with Astra ===
+The merger between Zeneca and Astra was announced in December 1998 and completed in April 1999. The new company, [[AstraZeneca]], became one of the largest pharmaceutical companies in the world, with a strong presence in both Europe and the United States.
+=== Legacy ===
+Although Zeneca as a standalone company ceased to exist after the merger, its legacy continues through AstraZeneca. The merger allowed for the pooling of resources and expertise, leading to the development of new and innovative treatments for various diseases.
+== Related pages ==
+* [[AstraZeneca]]
+* [[Imperial Chemical Industries]]
+* [[Pharmaceutical industry]]
 [[Category:Pharmaceutical companies of the United Kingdom]]
+[[Category:Defunct companies of the United Kingdom]]
 [[Category:Companies established in 1993]]
-[[Category:1999 disestablishments in the United Kingdom]]
+[[Category:Companies disestablished in 1999]]
-{{Pharma-company-stub}}